Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Oragenics, doing business as Oni BioPharma, has appointed Martin Handfield as its new director of R&D.
Subscribe to our email newsletter
Prior to joining Oni BioPharma, Dr Handfield was a tenured faculty member at the Center for Molecular Microbiology and Department of Oral Biology, University of Florida. Martin has received his PhD from Laval University in Canada.
Stanley Stein, president and CEO of Oni BioPharma, said: “We are delighted to have a scientist of Dr Handfield’s stature join us. His technical and administrative experience will be of great value to the company.”